+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Thyroid Cancer"

Medullary Thyroid Cancer - Global Strategic Business Report - Product Thumbnail Image

Medullary Thyroid Cancer - Global Strategic Business Report

  • Report
  • November 2025
  • 281 Pages
  • Global
From
From
Head and Neck Cancer (HNC) Market Report 2025 - Product Thumbnail Image

Head and Neck Cancer (HNC) Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
Oncology Biomarkers: Global Markets - Product Thumbnail Image

Oncology Biomarkers: Global Markets

  • Report
  • June 2023
  • 186 Pages
  • Global
From
From
From
Medical Oncology Compendium - Product Thumbnail Image

Medical Oncology Compendium

  • Book
  • March 2025
  • 20 Results (Page 1 of 1)
Loading Indicator

Thyroid cancer is a type of cancer that affects the thyroid gland, a small organ located in the neck. It is the most common type of endocrine cancer, accounting for around 1-2% of all cancers. Symptoms of thyroid cancer can include a lump in the neck, difficulty swallowing, and hoarseness. Diagnosis is typically made through imaging tests such as ultrasound, CT scan, and MRI. Treatment options include surgery, radiation therapy, and hormone therapy. The thyroid cancer market is a subset of the larger oncology market. It is a rapidly growing market, driven by increasing prevalence of the disease, technological advancements, and rising awareness. The market is highly competitive, with a number of players offering various treatments. Some companies in the thyroid cancer market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more